Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

A DNA repair complex functions as an Oct4/Sox2 coactivator in embryonic stem cells.

Fong YW, Inouye C, Yamaguchi T, Cattoglio C, Grubisic I, Tjian R.

Cell. 2011 Sep 30;147(1):120-31. doi: 10.1016/j.cell.2011.08.038.

2.

The transcriptional foundation of pluripotency.

Chambers I, Tomlinson SR.

Development. 2009 Jul;136(14):2311-22. doi: 10.1242/dev.024398. Review.

3.

Molecular mechanisms of pluripotency and reprogramming.

Na J, Plews J, Li J, Wongtrakoongate P, Tuuri T, Feki A, Andrews PW, Unger C.

Stem Cell Res Ther. 2010 Oct 25;1(4):33. doi: 10.1186/scrt33. Review.

4.

Induced pluripotent stem cells: what lies beyond the paradigm shift.

Cox JL, Rizzino A.

Exp Biol Med (Maywood). 2010 Feb;235(2):148-58. doi: 10.1258/ebm.2009.009267. Review.

5.

Role of Oct4 in maintaining and regaining stem cell pluripotency.

Shi G, Jin Y.

Stem Cell Res Ther. 2010 Dec 14;1(5):39. doi: 10.1186/scrt39. Review.

6.

Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs.

Kashyap V, Rezende NC, Scotland KB, Shaffer SM, Persson JL, Gudas LJ, Mongan NP.

Stem Cells Dev. 2009 Sep;18(7):1093-108. doi: 10.1089/scd.2009.0113. Review.

7.

The transcriptional network controlling pluripotency in ES cells.

Orkin SH, Wang J, Kim J, Chu J, Rao S, Theunissen TW, Shen X, Levasseur DN.

Cold Spring Harb Symp Quant Biol. 2008;73:195-202. doi: 10.1101/sqb.2008.72.001. Review.

PMID:
19478325
8.

Sox2/Oct4: A delicately balanced partnership in pluripotent stem cells and embryogenesis.

Rizzino A, Wuebben EL.

Biochim Biophys Acta. 2016 Jun;1859(6):780-91. doi: 10.1016/j.bbagrm.2016.03.006. Epub 2016 Mar 23. Review.

PMID:
26992828
9.
10.
11.

Pluripotent genes in avian stem cells.

Jean C, Aubel P, Soleihavoup C, Bouhallier F, Voisin S, Lavial F, Pain B.

Dev Growth Differ. 2013 Jan;55(1):41-51. doi: 10.1111/dgd.12021. Epub 2012 Dec 20. Review.

PMID:
23278808
12.

Pluripotency transcription factors and cancer stem cells: small genes make a big difference.

Liu A, Yu X, Liu S.

Chin J Cancer. 2013 Sep;32(9):483-7. doi: 10.5732/cjc.012.10282. Epub 2013 Feb 19. Review.

13.

Nanog and transcriptional networks in embryonic stem cell pluripotency.

Pan G, Thomson JA.

Cell Res. 2007 Jan;17(1):42-9. Review.

14.

Transcriptional regulatory networks in embryonic stem cells.

Chen X, Vega VB, Ng HH.

Cold Spring Harb Symp Quant Biol. 2008;73:203-9. doi: 10.1101/sqb.2008.73.026. Epub 2008 Nov 6. Review.

PMID:
19022762
15.

Transcriptional regulation of the Oct4 gene, a master gene for pluripotency.

Kellner S, Kikyo N.

Histol Histopathol. 2010 Mar;25(3):405-12. doi: 10.14670/HH-25.405. Review.

16.

[Yamanaka's factors and core transcription factors--the molecular link between embryogenesis and carcinogenesis].

Fuławka Ł, Donizy P, Hałoń A.

Postepy Hig Med Dosw (Online). 2014 Jun 5;68:715-21. Review. Polish.

17.

Sox2 and Oct-3/4: a versatile pair of master regulators that orchestrate the self-renewal and pluripotency of embryonic stem cells.

Rizzino A.

Wiley Interdiscip Rev Syst Biol Med. 2009 Sep-Oct;1(2):228-36. doi: 10.1002/wsbm.12. Review.

18.

Reprogramming to pluripotency: stepwise resetting of the epigenetic landscape.

Papp B, Plath K.

Cell Res. 2011 Mar;21(3):486-501. doi: 10.1038/cr.2011.28. Epub 2011 Feb 15. Review.

19.

Epigenetic regulation of reprogramming factors towards pluripotency in mouse preimplantation development.

Miyanari Y, Torres-Padilla ME.

Curr Opin Endocrinol Diabetes Obes. 2010 Dec;17(6):500-6. doi: 10.1097/MED.0b013e3283405325. Review.

PMID:
20962633
20.

Crosstalks between Raf-kinase inhibitor protein and cancer stem cell transcription factors (Oct4, KLF4, Sox2, Nanog).

Lee S, Wottrich S, Bonavida B.

Tumour Biol. 2017 Apr;39(4):1010428317692253. doi: 10.1177/1010428317692253. Review.

PMID:
28378634

Supplemental Content

Support Center